Advanced Code injection
0
Skip to Content
OBIO
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
OBIO
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
Folder: About
Back
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
Folder: Areas of Focus
Back
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
Folder: Events
Back
All Events
OBIO Investment Summit
Folder: News
Back
News & Press Releases
Tariff Relief Resources
Folder: Membership
Back
Membership
Member Log in
Job Board
Ontario Industry Updates obio 4/28/14 Ontario Industry Updates obio 4/28/14

Sernova’s Cell Pouch™ Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility

Read More
Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14

Spectral Updates Status Of EUPHRATES Trial

Read More
Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14

Profound Medical Announces Closing of Enrollment Into TULSA Clinical Trial for Treatment of Localized Prostate Cancer

Read More
Ontario Industry Updates obio 4/9/14 Ontario Industry Updates obio 4/9/14

Critical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer

Read More
Ontario Industry Updates obio 3/26/14 Ontario Industry Updates obio 3/26/14

Dalton Pharma Services Announces Completion of a Major Expansion in Aseptic Filling Capabilities

Read More
Ontario Industry Updates obio 2/28/14 Ontario Industry Updates obio 2/28/14

Sernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-Law

Read More
Ontario Industry Updates obio 2/12/14 Ontario Industry Updates obio 2/12/14

Debiopharm Group™ to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics

Read More
Ontario Industry Updates obio 2/12/14 Ontario Industry Updates obio 2/12/14

Frank Holler Joins Sernova’s Board of Directors

Read More
Ontario Industry Updates obio 2/3/14 Ontario Industry Updates obio 2/3/14

Sernova Announces Appointment of Cathy Steiner as CFO

Read More
Ontario Industry Updates obio 12/15/13 Ontario Industry Updates obio 12/15/13

Stem Cell Therapeutics Completes $33 Million Private Placement

Read More
Ontario Industry Updates obio 11/27/13 Ontario Industry Updates obio 11/27/13

Sernova Corp Engages Carson Seabolt and Network IR

Read More
Ontario Industry Updates obio 7/9/13 Ontario Industry Updates obio 7/9/13

Sernova Receives Patent Allowance for Therapeutic Immune Privileged Cell Technologies

Read More
Ontario Industry Updates obio 6/24/13 Ontario Industry Updates obio 6/24/13

Sernova Receives Patent Allowance for Therapeutic Cell Immune Protection Technology

Read More
Newer Posts
Become an OBIO® Member Today!

Contact us:

OBIO®
101 College St., Suite HL50

Toronto, ON M5G 1L7

OBIO © 2026

(416) 848 6839
info@obio.ca

Media Kit

NEWSlETTER Sign UP

Terms & Conditions